期刊文献+

尿毒症血清诱导人脐动脉平滑肌细胞成骨样转化和钙化的研究 被引量:2

Uremic serum induces osteogenic transition and calcification of human umbilical artery smooth muscle cells
原文传递
导出
摘要 目的研究尿毒症血清对原代培养人脐动脉平滑肌细胞(HUASMC)成骨样转化和细胞外基质钙沉积的影响。方法收集40例健康人、40例非透析尿毒症患者和45例透析尿毒症患者血清,检测有关生化指标。组织植块法原代培养HUASMC,分别给予健康人血清(对照组)、透析(透析组)和非透析(非透析组)尿毒症血清孵育。茜素红S钙沉积染色及甲氧.酚酞络合酮法检测细胞层钙盐含量。实时定量PCR、荧光定量法及WeStem印迹分别检测骨特异性碱性磷酸酶(BAP)、骨桥蛋白(OPN)和骨形成蛋白2(BMP2)基因以及蛋白表达。结果血清生化检测结果显示尿毒症血清较健康对照存在高磷、高脂、高全段甲状旁腺激素(iPTH)、高C反应蛋白(CRP)、自细胞介素6(IL-6)和低胎球蛋白A(P〈0.05),而透析组血清的三酰甘油、CRP、IL-6较非透析组血清高(P〈0.05)。与健康对照组相比,透析组和非透析组尿毒症血清均使HUASMC钙盐沉积更显著,BAP、OPN以及BMP2的表达上调(P〈0.05),且透析组血清作用更明显。结论尿毒症血清体外能够诱导HUASMC成骨样转化和钙化,提示可能和尿毒症相关的血管钙化有关。透析并发的微炎性反应状态可能加速了这一过程。 Objective To study the effect of uremic serum on the calcification and osteogenic transition of cultured human umbilical artery smooth muscle ceils (HUASMC). Methods Sera from 40 healthy controls (control group), 40 nondialysis uremic patients (nondialysis group) and 45 uremic patients on dialysis (dialysis group) were detected for biochemical indexes concerned and used to treat the cultured HUASMC. Alizarin red S stain was applied to examined calcium deposition in the cell layer. Calcium concentration was determined calorimetrically by the O- cresolphthalein complexone method, and corrected by total cell proteins. The mRNA expression of bone specific alkaline phosphatase (BAP), osteopontin (OPN) and bone morphogenetic protein 2 (BMP2) was estimated by realtime PCR. OPN and BMP2 protein expression was assessed by Western blotting and'fluorometry method was used to check the BAP concentration. Results Serum biochemical detection revealed that both uremic groups had higher levels of phosphate, triglyseride, iPTH, C-reactive protein (CRP) and IL-6, and lower level of fetuin-A than healthy control (P〈0.05). Furthermore, dialysis serum had higher levels of triglyseride, CRP and IL-6 than nondialysis serum(P〈0.05). Compared with control group, both uremic sera induced more cell layer calcium deposition and higher mRNA and protein expression levels of BMP2, BAP and OPN (P〈 0.05 ). Higher mRNA and protein expression levels of above factors were found in dialysis group as compared to nondialysis group (P〈0.05). Conclusions Uremic serum can induce HUASMC calcification and osteogenic transition in vitro, which may be one of the mechanisms involved in vascular calcification of ESRD patients. Microinflammatory state may promote the osteogenic transition and vascular calcification in dialysis patients.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2008年第4期265-270,共6页 Chinese Journal of Nephrology
基金 国家自然科学基金(30370653) 上海市教委基金(04BC35)
关键词 尿毒症 血清 肌细胞 平滑肌 脐动脉 成骨细胞样转化 血管钙化 Uremia Serum Myocytes, smooth muscle Umbilical artery Osteogenic transition Vascular calcification
  • 相关文献

参考文献15

  • 1Qunibi WR. Cardiovascular calcification in nondialyzed patients with chronic kidney disease. Semin Dial, 2007,20: 134-138.
  • 2London GM, Marchais SJ, Guerin AP, et al. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curt Opin Nephrol Hypertens, 2005,14:525-531.
  • 3Kizu A, Shioi A, Jono S, et al. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators. J Cell Biochem, 2004,93:1011- 1019.
  • 4Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res, 2000,87:E10-E17.
  • 5Derici U, El Nahas AM. Vascular calcifications in uremia: old concepts and new insights. Semin Dial, 2006,19:60-68.
  • 6Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol, 2004,15:2857-2867.
  • 7张敏芳,徐筱琪,钱家麒,戴慧莉,吴青伟,倪兆慧.骨相关蛋白与CRF患者并发动脉粥样硬化和瓣膜钙化的相关性[J].上海交通大学学报(医学版),2007,27(8):977-980. 被引量:4
  • 8Honda H, Qureshi AR, Heimburger O, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis, 2006,47:139-148.
  • 9Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000,342: 1478-1483.
  • 10Hassan MQ , Tare RS, Lee SH, et al. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem, 2006,281:40515-40526.

二级参考文献28

  • 1吴华.维持性透析患者心血管并发症的防治策略[J].中华肾脏病杂志,2006,22(3):140-142. 被引量:15
  • 2Davies MR,Hruska KA.Pathophysiological mechanisms of vascular calcification in end-stage renal disease[J].Kidney Int,2001,60(2):472-479.
  • 3Wang AY,Woo J,Wang M,et al.Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients[J].J Am Soc Nephrol,2001,12(9):1927-1936.
  • 4Adeera L,Ognjenka K,Brendan B,et al.Cardiovascular disease in patients with chronic kidney disease:getting to the heart of the matter[J].Am J Kidney Dis,2001,38(6):1398-1407.
  • 5Isoda K,Nishikawa K,Kamezawa Y,et al.Osteopontin plays an important role in the development of medial thickening and neointimal formation[J].Circ Res,2002,91(1):77-82.
  • 6Ohmori R,Momiyama Y,Taniguchi H,et al.Plasma osteopontin levels are associated with the presence and extent of coronary artery disease[J].Atherosclerosis,2003,170(2):333-337.
  • 7Nitta K,Ishizuka T,Horita S,et al.Soluble osteopontin and vascular calcification in hemodialysis patients[J].Nephron,2001,89(4):455-458.
  • 8Wada T,McKee MD,Steitz S,et al.Calcification of vascular smooth muscle cell cultures:inhibition by osteopontin[J].Cir Res,1999,84(2):166-178.
  • 9Speer MY,McKee MD,Guldberg RE,et al.Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice:evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo[J].J Exp Med,2002,196(8):1047-1055.
  • 10Heiss A,DuChesne A,Denecke B,et al.Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A.Formation of colloidal calciprotein particles[J].J Biol Chem,2003,278(15):13333-13341.

共引文献7

同被引文献15

  • 1张萍,陈江华,蒋华,王慧萍,金娟.尿毒症患者血管中膜钙化和骨特异性蛋白的表达[J].中华肾脏病杂志,2005,21(2):69-71. 被引量:11
  • 2Steitz SA, Speer MY, Curinga G, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfal and downregulation of smooth muscle lineage markers. Circ Res, 2001, 89: 1147-1154.
  • 3Jaffe IZ,Mendelsohn ME.Angiotensin Ⅱ and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.Circ Res,2005,96:643-650.
  • 4Jaffe IZ,Tintut Y,Newfell BG,et al.Mineralocorticoid receptor activation promotes vascular cell calcification.Arterioscler Thromb Vase Biol,2007,27:799-805.
  • 5Tyson KL,Reynolds JL,McNair R,et al.Osteo/ chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification.Arterioscler Thromb Vasc Biol,2003,23:489-494.
  • 6Moe SM,Duan D,Brain P,et al.Uremia induces the osteoblastdifferentiationfactorCbfalinhumanblood vessels.Kidney Int.2003,63:1003-1011.
  • 7Lombes M,Farman N,Bonvalet JP,et al.Identification and role of aldosterone receptors in the cardiovascular system.Ann Endocrinol,2000,61:41-46.
  • 8Christy C, Hadoke PW, Paterson JM, et al. 11 beta-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids. Hypertension, 2003, 42: 580-587.
  • 9Cai TQ,Wong B,Mundt SS,et al.Induction of 11 beta hydroxysteroid dehydrogenase type 1 but not 2 in human aortic smooth muscle cells by inflammatory stimuli.J Steroid Biochem Mol Biol,2001,77:117-122.
  • 10Ye P,Kenyon CJ,MacKenzie SM,et al.Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin Ⅱ.Endocrinology,2003,144:3321-3328.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部